•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.AARD Deadline Alert: SueWallSt Reminds Aardvark Therapeutics, Inc. (AARD) Investors of Securities Class Action Deadline on October 13, 2026
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in Aardvark Therapeutics, Inc. Lawsuit - AARD
Are You Looking for a Top Momentum Pick? Why Ardagh Metal Packaging S.A.
Ardagh Metal Packaging Q2 Earnings Call Highlights
Ardagh Metal Packaging S.A. Declares Quarterly Dividend
Ardagh Metal Packaging S.A. - Second Quarter 2026 Results
Ardagh Metal Packaging: This 8% Yielder Still Looks Great
Ardagh Metal Packaging to participate in a fireside chat at the Wells Fargo 16th Annual Industrials & Materials Conference
Aardvark Therapeutics: Regulatory Uncertainty Clouds ARD-101 Path Forward
Ardagh Metal Packaging S.A. - First Quarter 2026 Results
Ardagh Metal Packaging S.A. Declares Quarterly Dividend
Ardagh Metal Packaging: Execution Holds, Tailwinds Build, Valuation Undemanding
Ardagh Metal Packaging S.A. - Fourth Quarter and Full Year 2025 Results
Ardagh Metal Packaging S.A. Declares Quarterly Dividend
Ardagh Metal Packaging: A Shift In Fortunes, But Don't Get Too Excited Now
Aardvark Therapeutics Announces FDA Submission and IRB Approval of Amended Trial Protocol for Lead Candidate ARD-101, Expanding Eligibility in Phase 3 Study of Prader-Willi Syndrome
Ardagh Metal Packaging: A High Yield Built On Cash Flow, Not Accounting Earnings
NYSE to Commence Delisting Proceedings With Respect to Warrants of Ardagh Metal Packaging S.A. (AMBP.WS)
Ardagh Metal Packaging S.A. Release of Supplemental Company Information
Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates